There's knowledge in the number
The incidence of preterm birth continues to rise worldwide.* Approximately 8% of babies in Australia are born prematurely (<37 weeks) – that’s over 25,000 preterm births occurring annually or around 1 in 12 births.1
The causes are not fully understood, and in up to half of all preterm births, the cause remains unidentified. Although there are some related risk factors, the majority of women with traditional risk factors do not deliver early and of the patients who do, many do not have identifiable risk factors. Whether or not some risk factors are markers for other conditions and/or other risk factors is unknown.2
When a patient is experiencing symptoms of preterm labour, you need to determine if her risk of preterm birth is real or perhaps quite low. With Quantitative fFN testing, you can precisely measure the fetal fibronectin concentration to help quantify the risk of delivery before 34 weeks in both patients who have symptoms of preterm labour and high-risk patients. In a matter of minutes, understand the risk of preterm birth to help you construct an informed patient management plan.
The Quantitative Rapid fFN result should always be used in conjunction with information available from the clinical evaluation of the patient and other diagnostic procedures.6
Fetal fibronectin acts as an adhesive glycoprotein at the maternal-fetal interface that bonds maternal membranes to fetal membranes.
It is a biomarker for preterm delivery, and is highly associated with risk of preterm delivery when present in cervicovaginal secretions.
For patients who have symptoms of preterm labour, the detection of fetal fibronectin concentrations can help you quickly determine the risk of delivery within 2 weeks.
Stratification of Preterm Birth Risk by fFN Concentration3
For high-risk asymptomatic patients, the detection of fetal fibronectin concentrations can help you construct an informed and timely management plan.
Spontaneous Preterm Birth Rates in Asymptomatic High Risk Women According to Quantitative Fetal Fibronectin Categories6All comparisons for each gestational end point are statistically significant (p<0.01) except 10-29 ng/mL vs. 50-199 ng/mL and 200-499 vs.>500+ (p>0.1 for all gestational end points).
With the Rapid fFN PeriLynx System it's easy to get a quantitative answer in a matter of minutes.
Enter User ID, Rapid fFN 10Q Cassette Lot and Sample ID/Patient ID. When prompted, press ENTER.
Insert Rapid fFN 10Q Cassette into the analyser
Dispense sample into the Rapid fFN 10Q Cassette well.
Press START TEST and walk away.
Results ready in 10 minutes.